Latest International Subarachnoid Aneurysm Trial Stories
ALISO VIEJO, Calif. and NICE, France, Sept. 8, 2014 /PRNewswire/ -- Sequent Medical, Inc.
An experimental drug, clazosentan, reduced the risk of blood vessel spasm in patients with a brain aneurysm.
The Brain Aneurysm Foundation has announced the recipients of its annual research grants.
COLORADO SPRINGS, Colo., July 27, 2011 /PRNewswire/ -- Stryker Neurovascular, a division of Stryker Corporation, today announced the results of its Matrix and Platinum Science (MAPS) Trial during the Society of NeuroInterventional Surgery (SNIS) 8th Annual Meeting in Colorado Springs.
The addition of a simple stent can help prevent potentially lethal blood vessel bulges in the brain from recurring after they are repaired in a minimally invasive "coiling" procedure.
TUSTIN, Calif., May 31, 2011 /PRNewswire/ -- MicroVention-Terumo, Inc., a leader in developing, manufacturing and marketing interventional neurovascular devices, announced today the final 18-month follow-up data in a landmark international study.
PALO ALTO, Calif., Feb.
TUSTIN, Calif., Aug.
- An uxorious, effeminate, or spiritless man.
- A timorous, cowardly fellow.